Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor.
Tassev DV; Cheng M; Cheung NK; Cancer Gene Therapy, 2012, vol. 19, issue 2, p 84, ISSN 14765500. ISBN 14765500.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef